Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom

OBJECTIVES: To compare the real-world effectiveness of newer disease-modifying therapies (DMTs) vs injectables in children with relapsing-remitting multiple sclerosis (RRMS). METHODS: In this retrospective, multicenter study, from the UK Childhood Inflammatory Demyelination Network, we identified ch...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Neuroimmunol Neuroinflamm
Main Authors: Abdel-mannan, Omar A., Manchoon, Celeste, Rossor, Thomas, Southin, Justine-Clair, Tur, Carmen, Brownlee, Wallace, Byrne, Susan, Chitre, Manali, Coles, Alasdair, Forsyth, Rob, Kneen, Rachel, Mankad, Kshitij, Ram, Dipak, West, Siobhan, Wright, Sukhvir, Wassmer, Evangeline, Lim, Ming, Ciccarelli, Olga, Hemingway, Cheryl, Hacohen, Yael
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8143699/
https://ncbi.nlm.nih.gov/pubmed/34021056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000001008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados